Search Within

Mark Kris

Formats
  1. Journal Article (480)
  2. Meeting Abstract (356)
  3. Conference Paper (16)
  4. Book Section (9)
  5. Review (6)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (872)
  2. Solid Tumor Oncology Division (872)
  3. Thoracic Oncology (872)
  4. Department of Pathology and Laboratory Medicine (319)
  5. GSK Faculty (292)
  6. Human Oncology and Pathogenesis Program (225)

More Groups

People
  1. Gregory Riely (222)
  2. Marc Ladanyi (190)
  3. Vincent Miller (172)
  4. Valerie Rusch (130)
  5. Maria Arcila (123)
  6. Jamie Chaft (107)

More People

Years
  1. 2025 (7)
  2. 2024 (18)
  3. 2023 (27)
  4. 2022 (21)
  5. 2021 (21)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (235)
  2. Journal of Thoracic Oncology (131)
  3. Clinical Cancer Research (65)
  4. Cancer (33)
  5. Lung Cancer (31)
  6. Annals of Oncology (25)

More Publications

Publishers
  1. American Society of Clinical Oncology (253)
  2. Elsevier Inc. (179)
  3. American Association for Cancer Research (105)
  4. Oxford University Press (48)
  5. Wiley Blackwell (36)
  6. Elsevier Ireland Ltd. (30)

More Publishers

Results (872)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic significance of a diagnosis of multiple lung cancers
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Finley, D. J.; Travis, W. D.; Rusch, V. W.; Kris, M. G.; Zauderer, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Litvak, A. M.; Drilon, A. E.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P. K.; Kris, M. G.; Riely, G. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation
    Meeting Abstract

    Li, B. T.; Ross, D. S.; Chaft, J. E.; Hsu, M.; Kako, S.; Aisner, D. L.; Kris, M. G.; Varella-Garcia, M.; Arcila, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Assessing the performance of Watson for oncology, a decision support system, using actual contemporary clinical cases
    Meeting Abstract

    Kris, M. G.; Gucalp, A.; Epstein, A. S.; Seidman, A. D.; Fu, J.; Keesing, J.; Caroline, A.; Megerian, M.; Eggebraaten, T.; DeLima, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC 2.0)
    Meeting Abstract

    Kris, M. G.; Johnson, B. E.; Kwiatkowski, D. J.; Wistuba, I. I.; Berry, L. D.; Haura, E. B.; Socinski, M. A.; Ramalingam, S. S.; Glisson, B. S.; Waqar, S. N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Electronic medical record as a research tool: Virtual clinical trial comparing pemetrexed and gemcitabine, both given with cisplatin, in patients with lung adenocarcinomas
    Meeting Abstract

    Grigorenko, A.; May, P.; Kastango, N.; Thaler, H. T.; Wagner, I.; Caroline, A.; Kris, M. G.; Zauderer, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Steps in developing Watson for Oncology, a decision support system to assist physicians choosing first-line metastatic breast cancer (MBC) therapies: Improved performance with machine learning
    Meeting Abstract

    Fu, J.; Gucalp, A.; Zauderer, M. G.; Epstein, A. S.; Kris, M. G.; Keesing, J.; Caroline, A.; Megerian, M.; Eggebraaten, T.; DeLima, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes with chemotherapies and molecular characteristics of HER2-mutant lung cancers
    Meeting Abstract

    Eng, J.; Li, B. T.; Hsu, M.; Chaft, J. E.; Arcila, M. E.; Kris, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Utility of (18)F-FDG PET and CT to assess response to neoadjuvant chemotherapy
    Meeting Abstract

    Chaft, J. E.; Naidoo, J.; Dunphy, M.; Woo, K.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Kris, M. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save